{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T12:13:13Z","timestamp":1792498393626,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,3,13]],"date-time":"2023-03-13T00:00:00Z","timestamp":1678665600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Gynecol Obstet"],"DOI":"10.1007\/s00404-023-06962-5","type":"journal-article","created":{"date-parts":[[2023,3,26]],"date-time":"2023-03-26T22:14:37Z","timestamp":1679868877000},"page":"9-15","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Use of elexacaftor\/tezacaftor\/ivacaftor combination in pregnancy"],"prefix":"10.1007","volume":"309","author":[{"given":"Giuseppe","family":"Cimino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8648-8016","authenticated-orcid":false,"given":"Sara","family":"Sorrenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Murciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Galoppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorentina","family":"Ascenzioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Botta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Brunelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"On Behalf of the Sapienza University Working Group on Cystic Fibrosis in Pregnancy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Cavinato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cerrato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Cianfoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"D\u2019Ambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Delporto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Di Chiara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Galoppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Gasparrini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Ghirga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Giancotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Lagan\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mazzoccanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Mondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela Maria","family":"Montone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Murciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Pecorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Piccioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damiana","family":"Pompeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Spiniello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Terrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Troiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Zullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,3,13]]},"reference":[{"key":"6962_CR1","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1016\/S0140-6736(20)32542-3","volume":"397","author":"M Shteinberg","year":"2021","unstructured":"Shteinberg M, Haq IJ, Polineni D, Davies JC (2021) Cystic fibrosis. Lancet 397:2195\u20132211","journal-title":"Lancet"},{"key":"6962_CR2","unstructured":"https:\/\/www.cff.org\/Research\/Researcher-Resources\/Patient-Registry\/2019-Patient-Registry-Annual-Data-Report.pdf (Accessed on 24 Oct 2021)"},{"issue":"4922","key":"6962_CR3","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1126\/science.2475911","volume":"245","author":"JR Riordan","year":"1989","unstructured":"Riordan JR, Rommens JM, Kerem B et al (1989) Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science 245(4922):1066\u20131073. https:\/\/doi.org\/10.1126\/science.2475911. (Erratum.In:Science1989;245:1437)","journal-title":"Science"},{"key":"6962_CR4","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.ccm.2007.02.009","volume":"28","author":"V Sueblinvong","year":"2007","unstructured":"Sueblinvong V, Whittaker LA (2007) Fertility and pregnancy: common concerns of the aging cystic fibrosis population. Clin Chest Med 28:433\u2013443","journal-title":"Clin Chest Med"},{"key":"6962_CR5","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1378\/chest.118.1.85","volume":"118","author":"M Gilljam","year":"2000","unstructured":"Gilljam M, Antoniou M, Shin J, Dupuis A, Corey M, Tullis DE (2000) Pregnancy in cystic fibrosis. Fetal and maternal outcome. Chest 118:85\u201391","journal-title":"Chest"},{"issue":"2","key":"6962_CR6","first-page":"95","volume":"7","author":"A Barak","year":"2005","unstructured":"Barak A, Dulitzki M, Efrati O, Augarten A, Szeinberg A, Reichert N, Modan D, Weiss B, Miller M, Katzanelson D, Yahav Y (2005) Pregnancies and outcome in women with cystic fibrosis. Isr Med Assoc J 7(2):95\u201398 (PMID: 15729959)","journal-title":"Isr Med Assoc J"},{"issue":"6","key":"6962_CR7","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1016\/j.bpobgyn.2013.08.001","volume":"27","author":"EK Tan","year":"2013","unstructured":"Tan EK, Tan EL (2013) Alterations in physiology and anatomy during pregnancy. Best Pract Res Clin Obstet Gynaecol 27(6):791\u2013802. https:\/\/doi.org\/10.1016\/j.bpobgyn.2013.08.001. (Epub 2013 Sep 4 PMID: 24012425)","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"6962_CR8","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1056\/NEJMe1110323","volume":"365","author":"PB Davis","year":"2011","unstructured":"Davis PB (2011) Therapy for cystic fibrosis\u2013the end of the beginning? N Engl J Med 365:1734\u20131735","journal-title":"N Engl J Med"},{"key":"6962_CR9","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s40265-019-01233-7","volume":"79","author":"SM Hoy","year":"2019","unstructured":"Hoy SM (2019) Elexacaftor\/Ivacaftor\/tezacaftor: first approval. Drugs 79:2001\u20132007","journal-title":"Drugs"},{"key":"6962_CR10","volume":"13","author":"A Zaher","year":"2021","unstructured":"Zaher A, ElSaygh J, Elsori D, ElSaygh H, Sanni A (2021) A review of trikafta: triple cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapy. Cureus 13:e16144","journal-title":"Cureus"},{"key":"6962_CR11","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.139983","volume":"5","author":"G Veit","year":"2020","unstructured":"Veit G, Roldan A, Hancock MA et al (2020) Allosteric folding correction of F508del and rare CFTR mutants by elexacaftor-tezacaftor-ivacaftor (Trikafta) combination. JCI Insight 5:e139983","journal-title":"JCI Insight"},{"issue":"11","key":"6962_CR12","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.freeradbiomed.2008.09.012","volume":"45","author":"EK Krasnowska","year":"2008","unstructured":"Krasnowska EK, Pittaluga E, Brunati AM, Brunelli R, Costa G, De Spirito M, Serafino A, Ursini F, Parasassi T (2008) N-acetyl-l-cysteine fosters inactivation and transfer to endolysosomes of c-Src. Free Radic Biol Med 45(11):1566\u20131572. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2008.09.012. (Epub 2008 Sep 23 PMID: 18845245)","journal-title":"Free Radic Biol Med"},{"key":"6962_CR13","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1056\/NEJMoa1908639","volume":"381","author":"PG Middleton","year":"2019","unstructured":"Middleton PG, Mall MA, D\u0159ev\u00ednek P et al (2019) Elexacaftor-tezacaftor-ivacaftor for cystic fibrosis with a single Phe508del allele. N Engl J Med 381:1809\u20131819","journal-title":"N Engl J Med"},{"key":"6962_CR14","doi-asserted-by":"publisher","first-page":"1940","DOI":"10.1016\/S0140-6736(19)32597-8","volume":"394","author":"HGM Heijerman","year":"2019","unstructured":"Heijerman HGM, McKone EF, Downey DG et al (2019) Efficacy and safety of the elexacaftor plus tezacaftor plus ivacaftor combination regimen in people with cystic fibrosis homozygous for the F508del mutation: a double-blind, randomised, phase 3 trial [published correction appears in Lancet. 2020 May 30;395(10238):1694]. Lancet 394:1940\u20131948","journal-title":"Lancet"},{"issue":"2","key":"6962_CR15","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1016\/j.jcf.2017.09.006","volume":"17","author":"AT Trimble","year":"2018","unstructured":"Trimble AT, Donaldson SH (2018) Ivacaftor withdrawal syndrome in cystic fibrosis patients with the G551D mutation. J Cyst Fibros 17(2):e13\u2013e16. https:\/\/doi.org\/10.1016\/j.jcf.2017.09.006. (Epub 2017 Oct 24 PMID: 29079142)","journal-title":"J Cyst Fibros"},{"key":"6962_CR16","unstructured":"Vertex Pharmaceuticals Incorporated. Ivacaftor (Kalydeco) United States Prescribing Information. Available online: https:\/\/pi.vrtx.com\/files\/uspi_ivacaftor.pdf (accessed on 18 July 2020)"},{"key":"6962_CR17","doi-asserted-by":"publisher","first-page":"2706","DOI":"10.3390\/jcm9092706","volume":"9","author":"JL Taylor-Cousar","year":"2020","unstructured":"Taylor-Cousar JL (2020) CFTR modulators: impact on fertility, pregnancy, and lactation in women with cystic fibrosis. J Clin Med 9:2706","journal-title":"J Clin Med"},{"key":"6962_CR18","doi-asserted-by":"publisher","unstructured":"Jain R, Kazmerski TM, Zuckerwise LC, et al (2021) Pregnancy in cystic fibrosis: Review of the literature and expert recommendations [published online ahead of print, 2021 Aug 26]. J Cyst Fibros. https:\/\/doi.org\/10.1016\/j.jcf.2021.07.019","DOI":"10.1016\/j.jcf.2021.07.019"},{"issue":"2","key":"6962_CR19","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.jcf.2019.12.004","volume":"19","author":"S Vekaria","year":"2020","unstructured":"Vekaria S, Popowicz N, White SW, Mulrennan S (2020) To be or not to be on CFTR modulators during pregnancy: risks to be considered. J Cyst Fibros 19(2):e7\u2013e8. https:\/\/doi.org\/10.1016\/j.jcf.2019.12.004","journal-title":"J Cyst Fibros"},{"issue":"6","key":"6962_CR20","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/j.jcf.2018.05.009","volume":"17","author":"A Trimble","year":"2018","unstructured":"Trimble A, McKinzie C, Terrell M, Stringer E, Esther CR Jr (2018) Measured fetal and neonatal exposure to Lumacaftor and Ivacaftor during pregnancy and while breastfeeding. J Cyst Fibros 17(6):779\u2013782. https:\/\/doi.org\/10.1016\/j.jcf.2018.05.009","journal-title":"J Cyst Fibros"},{"issue":"5","key":"6962_CR21","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jhep.2014.06.016","volume":"61","author":"M Riccio","year":"2014","unstructured":"Riccio M, Carnevale G, Cardinale V, Gibellini L, De Biasi S, Pisciotta A et al (2014) The Fas\/Fas ligand apoptosis pathway underlies immunomodulatory properties of human biliary tree stem\/progenitor cells. J Hepatol 61(5):1097\u20131105. https:\/\/doi.org\/10.1016\/j.jhep.2014.06.016. (Epub 2014 Jun 19 PMID: 24953023)","journal-title":"J Hepatol"},{"key":"6962_CR22","doi-asserted-by":"publisher","unstructured":"Mainz JG, Michl RK, Beiersdorf N, et al. Successful Pregnancy of a Patient with Cystic Fibrosis Genotype F508del\/ F508del and Progressed Pulmonary Destruction on lumacaftor\/ivacaftor. Schwangerschaft einer F508del homozygoten CF-Patientin mit fortgeschrittener Lungendestruktion unter Therapie mit lumacaftor\/ivacaftor. Klin Padiatr. 2019;231(5):271\u2013273. doi:https:\/\/doi.org\/10.1055\/a-0973-8565","DOI":"10.1055\/a-0973-8565"},{"issue":"1","key":"6962_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.jogn.2016.08.011","volume":"46","author":"S Ladores","year":"2017","unstructured":"Ladores S, Kazmerski TM, Rowe SM (2017) A case report of pregnancy during use of targeted therapeutics for cystic fibrosis. J Obstet Gynecol Neonatal Nurs 46(1):72\u201377. https:\/\/doi.org\/10.1016\/j.jogn.2016.08.011","journal-title":"J Obstet Gynecol Neonatal Nurs"},{"issue":"1","key":"6962_CR24","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.jcf.2015.11.013","volume":"15","author":"R Kaminski","year":"2016","unstructured":"Kaminski R, Nazareth D (2016) A successful uncomplicated CF pregnancy while remaining on Ivacaftor. J Cyst Fibros 15(1):133\u2013134. https:\/\/doi.org\/10.1016\/j.jcf.2015.11.013","journal-title":"J Cyst Fibros"},{"issue":"4","key":"6962_CR25","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.jcf.2020.02.018","volume":"19","author":"EF Nash","year":"2020","unstructured":"Nash EF, Middleton PG, Taylor-Cousar JL (2020) Outcomes of pregnancy in women with cystic fibrosis (CF) taking CFTR modulators\u2014an international survey. J Cyst Fibros 19(4):521\u2013526. https:\/\/doi.org\/10.1016\/j.jcf.2020.02.018","journal-title":"J Cyst Fibros"},{"issue":"3","key":"6962_CR26","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.jcf.2021.03.006","volume":"20","author":"JL Taylor-Cousar","year":"2021","unstructured":"Taylor-Cousar JL, Jain R (2021) Maternal and fetal outcomes following elexacaftor-tezacaftor-ivacaftor use during pregnancy and lactation. J Cyst Fibros 20(3):402\u2013406. https:\/\/doi.org\/10.1016\/j.jcf.2021.03.006","journal-title":"J Cyst Fibros"},{"issue":"8","key":"6962_CR27","doi-asserted-by":"publisher","first-page":"e17427","DOI":"10.7759\/cureus.17427","volume":"13","author":"AM Kendle","year":"2021","unstructured":"Kendle AM, Roekner JT, Santillana EC, Kis LE, Cain MA (2021) Cystic fibrosis transmembrane conductance regulator modulators during pregnancy: a case series. Cureus 13(8):e17427. https:\/\/doi.org\/10.7759\/cureus.17427","journal-title":"Cureus"},{"issue":"5","key":"6962_CR28","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3390\/jpm11050418","volume":"11","author":"R Jain","year":"2021","unstructured":"Jain R, Taylor-Cousar JL (2021) Fertility, pregnancy and lactation considerations for women with CF in the CFTR modulator era. J Pers Med 11(5):418. https:\/\/doi.org\/10.3390\/jpm11050418","journal-title":"J Pers Med"},{"key":"6962_CR29","doi-asserted-by":"crossref","unstructured":"Jain R, Wolf A, Molad M, Taylor-Cousar J, Jr CRE, Shteinberg M (2022) Congenital bilateral cataracts in newborns exposed to elexacaftor-tezacaftor-ivacaftor in utero and while breast feeding. J Cyst Fibros 17:S1569-1993(22)01386-8","DOI":"10.1016\/j.jcf.2022.10.004"},{"issue":"4","key":"6962_CR30","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.jcf.2021.12.004","volume":"21","author":"B Collins","year":"2022","unstructured":"Collins B, Fortner C, Cotey A, Esther CRJ, Trimble A (2022) Drug exposure to infants born to mothers taking elexacaftor, tezacaftor, and Ivacaftor. J Cyst Fibros 21(4):725\u2013727","journal-title":"J Cyst Fibros"},{"key":"6962_CR31","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1136\/ebmed-2016-110401","volume":"21","author":"MH Murad","year":"2016","unstructured":"Murad MH, Asi N, Alsawas M, Alahdab F (2016) New evidence pyramid. Evid Based Med 21:125\u2013127","journal-title":"Evid Based Med"},{"key":"6962_CR32","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1016\/j.jcf.2017.01.008","volume":"16","author":"SL Heltshe","year":"2017","unstructured":"Heltshe SL, Godfrey EM, Josephy T, Aitken ML, Taylor-Cousar JL (2017) Pregnancy among cystic fibrosis women in the era of CFTR modulators. J Cyst Fibros 16:687\u2013694","journal-title":"J Cyst Fibros"},{"issue":"1","key":"6962_CR33","doi-asserted-by":"publisher","DOI":"10.1136\/bmjresp-2022-001289","volume":"9","author":"R Jain","year":"2022","unstructured":"Jain R, Magaret A, Vu PT et al (2022) Prospectively evaluating maternal and fetal outcomes in the era of CFTR modulators: the MAYFLOWERS observational clinical trial study design. BMJ Open Respir Res 9(1):e001289","journal-title":"BMJ Open Respir Res"}],"container-title":["Archives of Gynecology and Obstetrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-06962-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00404-023-06962-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00404-023-06962-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,5]],"date-time":"2024-01-05T06:06:06Z","timestamp":1704434766000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00404-023-06962-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,3,13]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["6962"],"URL":"https:\/\/doi.org\/10.1007\/s00404-023-06962-5","relation":{},"ISSN":["1432-0711"],"issn-type":[{"value":"1432-0711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,3,13]]},"assertion":[{"value":"12 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}